Comparison of antioxidant actions of estriol and estradiol on low density lipoproteins in post menopausal women;Comparación de la acción antioxidante de estriol y estradiol in vitro sobre lipoproteínas de baja densidad en mujeres postmenopáusicas

Revista Medica de Chile

Volumn 126, Issue 5, 1998, Pages 481-487

  Arteaga U, Eugenio ^a   Villaseca D, Paulina ^a   Rojas O, Auristela ^a   Arteaga Ll, Antonio ^a   Bianchi P, Marcelo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Antioxidants; Estradiol; Estriol; Lipid peroxidation

Indexed keywords

ANTIOXIDANT; ESTRADIOL; ESTRIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; LIPID PEROXIDATION; METABOLISM; MIDDLE AGED; POSTMENOPAUSE;

ANTIOXIDANTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTRADIOL; ESTRIOL; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MIDDLE AGED; POSTMENOPAUSE;

EID: 3242824992     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. STAMPFER MJ, COLDITZ GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
2. WALSH BW, SCHIFF I, ROSNER B, GREENBERG L, RAVNIKAR V, SACKS FM. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-204.
3. GANGAR KF, VYAS S, WHITEHEAD M, CROOK D, MEIRE H, CAMPBELL S. Pulsatility index in carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-42.
4. PINES A, FISMAN EZ, LEVO Y, ET AL. The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 1991; 164: 806-12.
5. SUBBIAH MTR, KESSEL B, AGRAWAL M, RAJAN R, ABPLANALP W, RYMASZEWSKI Z. Antioxidant potential of specific estrogens and lipid peroxidation. J Clin Endocrinol Metab 1993; 77: 1095-7.
6. SACK MN, RADER DJ, CANNON III RO. Oestrogen and inhibition of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-70.
7. POUMAY Y, RONVEAUX-DUPAL MF. Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation. J Lipid Res 1985; 26: 1476-80.
8. BRADFORD MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-54.
9. OHKAWA, H, OHISHI N, YAGI K. Assay for lipid peroxides in animal tissues by Thiobarbituric Acid Reaction. Anal Biochem 1979; 95: 351-8.
10. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WIZTUM JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
11. AVIRAM M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993; 98: 1-9.
12. BROWN MS, GOLDSTEIN JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 1981; 212: 628-35.
13. STEINBRECHER UO, PARTHASARANTHY S, LEAKE DS, ET AL. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-7.
14. GOLDSTEIN JL, HO YK, BASU SK, ET AL. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoproteins, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1976; 76: 333-7.
15. PALINSKI W. Lipoprotein oxidation: mechanisms and implications for atherogenesis. En: Born GVR, Schwartz CJ (eds). New horizons in coronary heart disease. London: Current Science Ltd 1993; pp 13.1-13.12.
16. WITZUM JL, STEINBERG D. Role of oxidized low-density lipoproteins in atherogenesis. J Clin Invest 1991; 88: 1785-92.
17. ESTERBAUER H, PUHL H, DIEBER-ROTHENEDER M, ET AL. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991; 23: 573-81.
18. JHA P, FLATHER M, LONN E, FARKOUH M, YUSUF S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-72.
19. nd Edition. Philadelphia, USA: JB Lippincott Co, 1995; p 1978.
20. MASSAFRA C, BUONOCORE G, GIOIA D, ET AL. Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women. J Clin Endocrinol Metab 1997; 82: 173-5.
21. SARREL P. Blood Flow. En: Lobo RA (ed). Treatment of the postmenopausal women. Basic and clinical aspects. New York: Raven Press, 1994; pp 251-62.
22. SASSON S. Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol (Paris) 1991; 39: 59-69.
23. CLARK JH, HARDIN JW, MCCORMACK SA. Estrogen receptor binding and growth of the reproductive tract. Pediatrics 1978; 62: 1121-7.